State Ledger
Company profile

Immunovant, Inc. CIK 1764013

Ticker
IMVT (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Durham, NC 27713
Fiscal year end
2026 (FY)
Market Data
Close
$30.47
Change
+$0.19
Change %
0.61%
Volume
77,407

IMVT · trading date Oct 9, 2026 · previous close $30.28 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$505.61M
Total assets
$957.01M
Total liabilities
$104.42M
Stockholders' equity
$852.59M
Cash & equivalents
$902.11M
Operating income
—
Operating cash flow
-$407.31M
Capital expenditures
$8.0K

Fiscal year 2026, via 10-K filed 2026-05-20. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$407.32M
Free cash flow margin
—
Liabilities / assets
10.9%
Equity / assets
89.1%
CapEx / revenue
—
Operating cash flow / net income
0.81×

Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026 — -$505.61M $957.01M $104.42M $852.59M
2025 — -$413.84M $776.22M $68.78M $707.45M
2024 — -$259.34M $666.37M $48.61M $617.76M
2023 — -$210.96M $405.84M $43.34M $362.49M
2022 — -$156.73M $515.56M $45.74M $469.83M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-03
Financials filed via
Form 10-K
filed 2026-05-20

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Durham, NC 27713
1000 PARK FORTY PLAZA
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:49 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to North Carolina — Public Companies